share_log

6-K: Blenrep Shows Significant Overall Survival Benefit, Reducing the Risk of Death by 42% in Multiple Myeloma at or After First Relapse

6-K: Blenrep Shows Significant Overall Survival Benefit, Reducing the Risk of Death by 42% in Multiple Myeloma at or After First Relapse

6-K:Blenrep显示出显着的总体生存益处,将多发性骨髓瘤患者首​​次复发时或复发后的死亡风险降低42%
美股SEC公告 ·  12/10 03:41
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息